Comparison of post-operative bleeding incidence in laser hemorrhoidoplasty with and without hemorrhoidal artery ligation: a double-blinded randomized controlled trial

Table 2 Association of bleeding incidence in supplementation of HAL in patients undergoing LHP

Bleeding incidence		Procedure		P value
Bleeding incidence		LHP n = 38 (%)	LHP + HAL n = 38 (%)	P value
Overall	Present	9 (23.7)	14 (36.8)	0.212^a
Overall	Absent	29 (76.3)	24 (63.2)	0.212^a
1-day post-operatively	Present	3 (7.9)	6 (15.8)	0.480^a
1-day post-operatively	Absent	35 (92.1)	32 (84.2)	0.480^a
1-week post-operatively	Present	6 (15.8)	7 (18.4)	0.761^a
1-week post-operatively	Absent	32 (84.2)	31 (81.6)	0.761^a
6-weeks post-operatively	Present	0 (0.0)	1 (2.6)	1.000^a
6-weeks post-operatively	Absent	38 (100.0)	37 (97.4)	1.000^a
Severity
Presence of mild bleeding
1-day post-operatively (n = 9)		3 (7.9)	6 (15.8)	0.480^a
1-week post-operatively (n = 6)		3 (7.9)	3 (7.9)	1.000^a
6-weeks post-operatively (n = 1)		0 (0.0)	1 (2.6)	1.000^a
Presence of moderate bleeding
1-day post-operatively (n = 0)		0 (0.0)	0 (0.0)	N/A
1-week post-operatively (n = 6)		2 (5.3)	4 (10.5)	0.674^a
6-weeks post-operatively (n = 0)		0 (0.0)	0 (0.0)	N/A
Presence of severe bleeding
1-day post-operatively (n = 0)		0 (0.0)	0 (0.0)	N/A
1-week post-operatively (n = 2)		1 (2.6)	1 (2.6)	1.000^a
6-weeks post-operatively (n = 0)		0 (0.0)	0 (0.0)	N/A

Data are presented as n (%)
LHP laser haemorrhoidoplasty, HAL haemorrhoidal artery ligation, N/A not applicable
^aChi-square test (χ²); a p value <0.05 denotes a statistically significant result

ISSN: 1471-2482